INTRODUCTION
Bipolar disorder is a major mental illness affecting 1% of the world's population. Although numerous treatments are available, lithium retains a key position in major treatment guidelines, effectively treating and preventing illness episodes and reducing suicidal behaviour (Tondo, Vazquez, & Baldessarini, 2014) . The mechanisms by which lithium achieves these effects are not fully understood and we lack detailed information about its tissue level distribution and how this relates to its actions in the brain.
Various neuroimaging techniques have been used to identify structural and functional changes that occur within the brain during treatment with lithium. For instance, cross-sectional structural MRI studies have revealed that treatment with lithium is associated with increased grey matter volume and cortical thickness (Hafeman, Chang, Garrett, Sanders, & Phillips, 2012; Hibar et al., 2017; Hibar et al., 2016; Moore, Bebchuk, Wilds, Chen, & Manji, 2000) and longitudinal studies have reported progressive increases in measures of grey matter volume following lithium initiation in bipolar disorder (Lyoo et al., 2010) . These studies have generally shown that the effects of lithium on MRI estimates of grey matter volume are not uniform across the brain, and may localise to candidate regions such as the hippocampus, amygdala, anterior cingulate and prefrontal cortex (Hibar et al., 2017; Hibar et al., 2016; Monkul et al., 2007; Zung et al., 2016) .
Whilst the effects of lithium on white matter are not fully understood, it has been consistently shown to positively influence measures of white matter integrity. Diffusion MRI (dMRI) enables the examination of the microstructural properties of tissue by mapping water molecule diffusion. In pure fluid states, water diffuses equally in all directions (isotropic). In neurons however, water cannot readily cross the hydrophobic myelin sheaths and diffusion is restricted (anisotropic) along the direction of the axon. The parallel configuration of axons in white matter renders this directional diffusion detectable at the microstructural scale, reflected in the dMRI-derived parameter of fractional anisotropy (FA). Decreases in FA within white matter have been shown to correspond with demyelination and axonal injury (Boretius et al., 2012; Song et al., 2002) , such that FA is held to be a measure of white matter integrity. A number of studies have examined regional FA in bipolar disorder, generally reporting low FA values in white matter regions and tracts involved in mood regulation (Adler et al., 2006; Benedetti et al., 2011; Bruno, Cercignani, & Ron, 2008) . The findings from whole brain dMRI studies are heterogeneous, but meta-analysis has identified two significant clusters of low FA in the right hemisphere (parahippocampal gyrus and the anterior cingulate/subgenual cingulate cortex) (Marlinge, Bellivier, & Houenou, 2014) . White matter FA is greater in patients with bipolar disorder taking lithium compared to those on other medications, and the differences may be a function of the duration of treatment (Gildengers et al., 2015; Haarman et al., 2016; Macritchie et al., 2009) . In a recent region of interest study using longitudinal dMRI data from adolescents with bipolar disorder (Kafantaris, Spritzer, Doshi, Saito, & Szeszko, 2017) , FA values in the cingulum hippocampus were lower than healthy controls but increased following treatment with lithium, the effect being most marked in responders. However, in the absence of a whole brain analysis, it remains unclear whether this effect of lithium is regionally specific or global.
Regionally specific effects of lithium would indicate either that brain regions are differentially sensitive to its effects or that the drug itself is heterogeneously distributed across the brain. Recent advances in multinuclear MRI ( 7 Li-MRI) have permitted the rapid determination of brain lithium distribution in vivo (Smith et al., 2018) , demonstrating a heterogeneous distribution of lithium in bipolar disorder, in keeping with previous rodent imaging and human magnetic resonance spectroscopy studies (Lee et al., 2012; Zanni et al., 2017) . It would therefore be reasonable to propose that the effects of lithium on white matter integrity relate to its regional concentration and the combination of Li-MRI and dMRI affords the capability to explore this.
In this study we compared generalised FA (gFA), a measure analogous to FA with the ability to account for crossing fibres (Tuch, 2004) , across white matter regions of interest in patients with bipolar disorder receiving lithium, those taking other maintenance medications but naïve to lithium, and a healthy comparator group.
Patients receiving lithium additionally underwent an assessment of brain lithium distribution by 7 Li-MRI. We hypothesised that gFA values in patients receiving lithium treatment would exceed those of patients on other treatments and be comparable to healthy controls, and that the areas of the brain with the greatest signal intensity on 7 Li-MRI would be those with the largest magnitude gFA in the lithium treated group.
METHODS

Subjects and assessments
Twenty-nine euthymic subjects with a diagnosis of bipolar disorder (I or II) and sixteen healthy control subjects recruited to the Bipolar Lithium Imaging and Spectroscopy Study (BLISS) were studied. Of those with bipolar disorder, twelve were taking lithium as a long-term treatment (Bipolar Disorder Lithium, BDL) and seventeen were taking other maintenance treatments but were naïve to lithium (Bipolar Disorder Control, BDC). The healthy control subjects (HC) had no history of psychiatric illness and were not taking any psychotropic medications. All subjects provided written informed consent and the study was granted a favourable ethical opinion by a United Kingdom National Research Ethics Committee (14/NE/1135). Exclusion criteria were contraindications to magnetic resonance examination, current or recent harmful drug or alcohol use, comorbid psychiatric diagnosis, learning disability, impairment of capacity or current liability to detention under the Mental Health Act 1983 (amended 2007). Diagnosis was confirmed through clinical interview using the NetSCID diagnostic tool (a validated online version of the Structured Clinical Interview for DSM-V Criteria; Telesage, Inc., Chapel Hill, NC, USA). All interviews and objective ratings were conducted by a trained research assistant (CJF) and discussed with a senior psychiatrist (DAC). Euthymic mood state was confirmed at entry to the study, defined as scores of less than seven on both the 21-item Hamilton Depression Rating Scale (HAM-D) and the Young Mania Rating Scale (YMRS). BDL subjects had taken lithium carbonate (Priadel™ modified release once daily) regularly for at least one year at the time of recruitment and all were taking at least one concomitant medication.
All scans were performed at 9 am and the BDL subjects were instructed to take their lithium as usual the night before. Blood samples were taken immediately prior to scanning for confirmation that serum lithium levels fell within the target therapeutic range (0.6 -1.0 mmol/L).
Image acquisition
Scanner and coil systems: all MR data were acquired on a Philips 3T Achieva scanner (Philips Medical Systems, Best, The Netherlands) with 1 H structural and diffusion weighted imaging performed using a Philips 8-channel SENSE head coil in all subjects. lasting approximately eight minutes, was conducted thrice without a notable interval and the three scan dynamics were averaged in complex form.
T1-weighted imaging acquisition
Image processing and analysis
All T1w, dMRI and Li imaging session were segmented into three tissue classes (grey matter, white matter and cerebrospinal fluid) using the FMRIB Automated Segmentation Tool (Zhang, Brady, & Smith, 2001 ).
Diffusion-weighted image processing: dMRI images from every subject were corrected for motion and eddycurrent distortions using the eddy correct and bvec rotation utility in FSL (Andersson & Sotiropoulos, 2016) . The b0 image was used as the reference image for realignment of all the dMRI images, and mean displacement for each subject across the acquisition was calculated. One-way ANOVA failed to reveal a significant difference between the mean displacement between the three groups (p = 0.64). Subsequently, skull-stripping was performed on the b0 image using FSL's Brain Extraction Tool (Smith et al., 2002) and images were visually inspected to ensure skull-stripping had occurred successfully. A Constant Solid Angle (Q-Ball) model with fourthorder spherical harmonics was fitted to motion-corrected dMRI images using the Python package Dipy (version 0.11) (Garyfallidis et al., 2014) yielding an estimation of gFA for each brain voxel. gFA was chosen in favour of FA owing to the ability of the Q-Ball model to account for crossing fibres (Tuch, 2004) . gFA maps were co-registered with structural T1w images using FMRIB's Linear Image Registration Tool (Jenkinson et al., 2012) with 6 degrees of freedom. gFA maps were transformed into MNI space by applying the transformation matrix obtained from registering the structural T1w images to the standard MNI 2mm brain using FMRIB's Non Linear Image
Registration Tool (Andersson, Jenkinson, & Smith, 2007) .
For the analysis of mean gFA across the white matter for each subject in MNI space, the mean gFA across all voxels in the John Hopkins University (JHU) White-Matter Tractography region of interest (ROI) atlas (Wakana, Jiang, Nagae-Poetscher, van Zijl, & Mori, 2004) was calculated. To quantify differences across groups (BDC, BDL, and HC), the effects of age and sex were regressed out and the residuals were compared between the groups.
One-way ANOVA was used to test for group differences in mean white matter gFA residuals, followed by post-hoc t-tests (applying Tukey's correction for multiple comparisons) to determine the direction of effect. Figure   1A shows a schematic outline of this processing step.
For a ROI based analysis of gFA in MNI space, region-wise differences in mean gFA were determined for each JHU ROI by computing effect sizes (Cohen's d) between the groups. Effect sizes were computed using residuals after regressing out the effects of age and sex for each individual ROI. Li-MRI voxel was investigated at white matter thresholds ranging from 0-100% in steps of 25%. In essence, we performed all analyses steps at the resolution of the lithium images in subject space. This ensured that no effect of up-sampling, or interpolation of low resolution images would affect our results. Fig. 1B shows a schematic outline of this processing step.
To enable a group analysis of the association between gFA and 7 Li-MRI signal intensity, a linear mixed effects model was used to account for inter-subject variations (Winter, 2013) . As fixed effects, we entered gFA, age and sex (without interaction term) into the model. As random effects, we had intercepts for subjects and bysubject random slopes for the effect of Supplementary Information A shows the full linear mixed effect analysis and additional tests to determine the random effects.
[FIGURE 1 HERE]
RESULTS
Group characteristics
Twelve BDL subjects (five women; mean age: 46 ± 13 SD years), seventeen BDC subjects (eleven women; mean age: 44 ± 12 SD years) and sixteen HC subjects (ten women; mean age: 49 ± 3 SD years) were included in the analysis. One BDL subject was excluded from the 7 Li-MRI analysis because their data was acquired during the 7 Li-MRI sequence development phase and the acquisition protocol was inconsistent with the other subjects in the study. The groups did not differ in mean age (p = 0.77), sex distribution (p = 0.45) or educational level (p = 0.87) ( Table 1) . ANOVA followed by post-hoc testing of clinical information revealed that the HC group had significantly lower HAM-D scores than the BD group as a whole (p = 0.03).
[TABLE 1 HERE]
All subjects with bipolar disorder were taking some form of medication at time of scanning. Fisher's exact tests were performed in order to compare the use of medication class between diagnostic groups. Barring lithium, no significant differences were found between the bipolar disorder groups across all major medication classes.
Medication usage information for each group and their corresponding p values are provided in Table 2 .
[TABLE 2 HERE]
Mean white matter gFA comparison between groups
A significant negative correlation (r = -0.52; p = 0.0002) between mean white matter gFA and age was found across all subjects. This was anticipated as FA has previously been shown to be negatively associated with age in adulthood (Lebel, Caverhill-Godkewitsch, & Beaulieu, 2010) . After regressing out the effects of age and sex, ANOVA revealed a significant difference between the groups (F(2, 42); p = 0.02; Figure 2b ) and post hoc tests revealed that the BDL and HC groups exhibited higher mean white matter gFA residuals compared to the BDC group (t = 2.5, p = 0.05; t = 2.7, p = 0.03, respectively). No differences were found between the BDL and HC groups (t = 0.02 p = 1).
Region of interest gFA group comparison
Region-wise gFA effect sizes for the comparison BDL > BDC are shown in Figure 3 . Subjects taking lithium exhibited higher gFA in 44 out of 48 ROIs compared to those taking other medications for bipolar disorder but naïve to lithium, with eight regions exhibiting an effect size of greater than 0.8 (signifying a large effect). Effect sizes ranged from -0.3 to + 1.5, indicating spatial heterogeneity in gFA differences between the groups. All ROI labels and their corresponding effect sizes are provided in Supplementary Information B.
[
FIGURE 3 HERE]
Co-localisation of lithium and gFA
The relationship between white matter integrity and the spatial distribution of lithium was determined in a linear mixed effect analysis of Using linear mixed effect modelling, we also tested the random slope model against a random intercept model to determine whether there was evidence to suggest that individual subjects need to be modelled with individual slopes. These results revealed there was a significant difference in the models accounting for a subject specific slope versus one that does not (p < 0.05). The full linear mixed effect analysis is described in detail in Supplementary Information A.
[FIGURE 4 HERE]
DISCUSSION
In this study, we report that patients with bipolar disorder treated with lithium have white matter gFA values comparable to healthy controls and greater than bipolar disorder patients receiving other medications. Further, as hypothesised, the spatial distribution of the 7 Li-MRI signal positively correlated with gFA. Our findings add to the growing literature suggesting lithium that use is associated with a rectification of the microstructural MRI abnormalities that occur in bipolar disorder (Hafeman et al., 2012; Hibar et al., 2017; Hibar et al., 2016; Kafantaris et al., 2017; Moore et al., 2000) .
One major challenge in our work was the relatively low resolution of the lithium image compared to the T1w and dMRI images, meaning that a single lithium voxel often contained mixed tissue types. To enable a fair comparison, we performed all analysis using the lithium signal in native space at the resolution of the lithium image. Our results from linear mixed effect modelling show the emergence of a robust and highly significant effect (p < 0.01) of the lithium signal in explaining gFA in lithium voxels containing over 50% of white matter.
Furthermore, we found a significant difference between the random intercept model and the random slope model, potentially suggesting subject-specific slopes of the gFA ~ lithium relationship. However, these results reached statistical power through the use of linear mixed effect modelling by estimating associations on the BDL group as a whole. Our data did not permit us to derive reliable subject specific slopes. Hence, at the present stage, we cannot conclude the significance of individual slopes, nor can we infer the causality of the association between gFA and lithium.
Lithium is purported to exert a range of neurorestorative effects (Forlenza, De-Paula, & Diniz, 2014; Quiroz, Rodrigo, Zarate, Jr, & Manji, 2010) , many of which could influence white matter microstructure and affect gFA.
For instance, lithium is known to inhibit glycogen synthase kinase 3β and inhibition of this enzyme increases the number of oligodendrocytes and promotes peripheral nerve myelination in mice (Azim & Butt, 2011; Makoukji et al., 2012) . Lithium treatment has been shown to be positively associated with MRI measures of white matter integrity (Gildengers et al., 2015; Haarman et al., 2016; Macritchie et al., 2009 ) as well as protect against a decrease in white matter volume over time (Berk et al., 2017) . Lithium has been associated with an increase in FA in the cingulum hippocampus in a recent longitudinal study of adolescents with bipolar disorder, where responders to treatment showed the greatest percentage increase in FA (Kafantaris et al., 2017) .
Lithium related alterations in water homeostasis also require consideration in the interpretation of its effects on dMRI-derived measures. Rats fed lithium for five weeks have elevated brain tissue water content (Phatak, Shaldivin, King, Shapiro, & Regenold, 2006) and it has been argued that this may underpin the volumetric changes detected in neuroimaging studies in bipolar disorder (Regenold, 2008) . Phatak et al., 2006 reported that water content was significantly increased only in the frontal cortex, suggesting regional specificity of action but not accounting for the more widespread cortical differences in grey matter volume on MRI. However, increased water content driven by lithium cannot easily explain its effects on FA, as widespread increases in free water content within white matter has been linked to decreased FA in first-episode patients with psychosis (Lyall et al., 2017) .
In practice, lithium may be preferentially prescribed to those deemed more likely to respond to it, to those with more severe presentations or when there is confidence that the patient will manage regular blood level monitoring. It could be argued that the differences in FA between patients treated with lithium and those on other medications reflects an as yet unidentified illness characteristic driving a selection bias rather than a direct action of lithium. However, longitudinal data (Kafantaris et al., 2017) and our finding of a relationship between gFA and regional lithium concentration strongly suggests that lithium is directly involved.
Further, the effects of lithium on white matter may be linked to its clinical efficacy, holding the potential to predict therapeutic response (Berk et al., 2017; Kafantaris et al., 2017) . In an elderly population with bipolar disorder, a longer duration of lithium treatment was found to be associated with higher FA but interestingly, not with better cognitive performance (Gildengers et al., 2015) . Investigating patients with bipolar disorder initiating lithium for the treatment of depression, Machado-Vieira et al. (2016) reported that serum and brain lithium concentration only correlated in those who entered remission, but their 7
Li magnetic resonance spectroscopy sequence did not permit regional localisation. The potential to use changes in FA as a predictor of therapeutic response may be enhanced by being able to co-localise FA with the spatial distribution of lithium. In future work, multimodal imaging studies utilising 7
Li-MRI and larger cohorts that permit the segregation of subjects into groups based upon lithium response may reveal localised response-specific relationships between regional brain lithium concentration and MRI derived measures such as gFA. Such approaches may help characterise lithium responders and move us a step closer to personalised medicine in bipolar disorder.
In conclusion, we report dMRI results that are consistent with the previous literature and a novel observation of the correlation between gFA and regional lithium concentration. Li-MRI with clear potential to improve the spatial resolution of lithium images. The ability to co-localise a psychotropic medication with its effect in vivo spurs us to meet these challenges. Duration of lithium treatment (years) 8(9) n/a n/a n/a Priadel™ dose (mg) 900 (130) n/a n/a n/a Serum lithium concentration (mmol/L) 0.8(0.13) n/a n/a n/a LISERS score 17(13) n/a n/a n/a Li signal as a fixed effect.
